Home
KZR
KZR News

Latest Kezar Life Sciences Inc. (KZR) News on December 18, 2024

Kezar struck again with second FDA hold

Clinical Trials Arena

a month ago

Kezar struck again with second FDA hold

MT Newswires

2 months ago

Kezar Life Sciences to Implement 1-for-10 Reverse Stock Split

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split

Business Wire

2 months ago

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split

Kezar Life Sciences discontinues lupus nephritis programme after fatalities

Clinical Trials Arena

2 months ago

Kezar Life Sciences discontinues lupus nephritis programme after fatalities

MT Newswires

2 months ago

Kezar Life Sciences Gets Nod to Proceed With Autoimmune Hepatitis Trial; Ends Lupus Nephritis Study

Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study

Benzinga

2 months ago

Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study

MT Newswires

2 months ago

Kezar Life Sciences Rejects Concentra Biosciences Takeover Bid, Adopts Rights Plan

Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan

Business Wire

2 months ago

Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan

Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update

Business Wire

2 months ago

Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update

What Makes Kezar Life Sciences (KZR) a New Buy Stock

Zacks

2 months ago

What Makes Kezar Life Sciences (KZR) a New Buy Stock

MT Newswires

2 months ago

Kezar Life Sciences Receives Takeover Proposal From Concentra Biosciences

Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal

Business Wire

2 months ago

Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal

TANG CAPITAL MANAGEMENT LLC Acquires New Stake in Kezar Life Sciences Inc

GuruFocus.com

2 months ago

TANG CAPITAL MANAGEMENT LLC Acquires New Stake in Kezar Life Sciences Inc

FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths

Benzinga

2 months ago

FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths

FDA places hold on Kezar Life Sciences’ trial for lupus nephritis treatment

Clinical Trials Arena

2 months ago

FDA places hold on Kezar Life Sciences’ trial for lupus nephritis treatment

Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis

Business Wire

2 months ago

Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis

Kezar Life Sciences suspends subject enrolment in trial of lupus nephritis drug

Clinical Trials Arena

3 months ago

Kezar Life Sciences suspends subject enrolment in trial of lupus nephritis drug

MT Newswires

3 months ago

Kezar Life Sciences Suspends Enrollment, Dosing in Phase 2b Trial of Zetomipzomib in Active Lupus Nephritis Patients

Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients

Business Wire

3 months ago

Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients

Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Business Wire

3 months ago

Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Kezar stalls solid tumour trial to focus on autoimmune disease candidate

Pharmaceutical Technology

4 months ago

Kezar stalls solid tumour trial to focus on autoimmune disease candidate

Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Business Wire

4 months ago

Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

5 months ago

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

6 months ago

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference

Business Wire

7 months ago

Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference

Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update

Business Wire

7 months ago

Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

7 months ago

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

Insider Monkey

8 months ago

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

8 months ago

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update

Business Wire

9 months ago

Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Business Wire

9 months ago

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference

Business Wire

10 months ago

Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference

Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis

Business Wire

10 months ago

Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

InvestorPlace

10 months ago

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

3 Penny Stocks Poised for an Unbelievable 1,000% Jump

InvestorPlace

a year ago

3 Penny Stocks Poised for an Unbelievable 1,000% Jump

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

PR Newswire

a year ago

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

PR Newswire

a year ago

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

Panacea Financial Named Exclusive Practice Finance Provider for American Dental Association Members across the United States

PR Newswire

a year ago

Panacea Financial Named Exclusive Practice Finance Provider for American Dental Association Members across the United States

Primis Financial Corp (FRST) Reports Notable Improvement in Q4 2023 Earnings

GuruFocus.com

a year ago

Primis Financial Corp (FRST) Reports Notable Improvement in Q4 2023 Earnings

Velo3D Announces Key Strategic Priorities for Growth in 2024

Business Wire

a year ago

Velo3D Announces Key Strategic Priorities for Growth in 2024

Hanover Bancorp, Inc. Reports Earnings for the Fourth Calendar Quarter highlighted by Increased Net Income and Net Interest Income and Strong Non-interest Income

GlobeNewswire

a year ago

Hanover Bancorp, Inc. Reports Earnings for the Fourth Calendar Quarter highlighted by Increased Net Income and Net Interest Income and Strong Non-interest Income

Pixelworks Collaborates with OnePlus to Deliver Unparalleled Gaming Experience on OnePlus 12 Global Version

PR Newswire

a year ago

Pixelworks Collaborates with OnePlus to Deliver Unparalleled Gaming Experience on OnePlus 12 Global Version

Shareholders in Lake Shore Bancorp (NASDAQ:LSBK) are in the red if they invested five years ago

Simply Wall St.

a year ago

Shareholders in Lake Shore Bancorp (NASDAQ:LSBK) are in the red if they invested five years ago

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

GlobeNewswire

a year ago

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

While institutions own 33% of Lands' End, Inc. (NASDAQ:LE), individual investors are its largest shareholders with 57% ownership

Simply Wall St.

a year ago

While institutions own 33% of Lands' End, Inc. (NASDAQ:LE), individual investors are its largest shareholders with 57% ownership

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

GlobeNewswire

a year ago

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

a year ago

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

Safe Bulkers, Inc.'s (NYSE:SB) top owners are individual investors with 37% stake, while 26% is held by insiders

Simply Wall St.

a year ago

Safe Bulkers, Inc.'s (NYSE:SB) top owners are individual investors with 37% stake, while 26% is held by insiders

BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease

PR Newswire

a year ago

BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease

Business Wire

a year ago

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

GuruFocus.com

a year ago

Shimmick Corp (SHIM) Reports Solid Earnings Amidst Strategic Shifts

GlobeNewswire

a year ago

Shimmick Corp. Announces Third Quarter 2023 Results

Gevo VP of Government Relations Lindsay Fitzgerald and VP of Finance & Strategy Eric Frey to Participate in a Water Tower Research Fireside Chat on Tuesday, December 19th at 10:00 am ET

GlobeNewswire

a year ago

Gevo VP of Government Relations Lindsay Fitzgerald and VP of Finance & Strategy Eric Frey to Participate in a Water Tower Research Fireside Chat on Tuesday, December 19th at 10:00 am ET

Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth

InvestorPlace

a year ago

Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth

Don't Race Out To Buy First Guaranty Bancshares, Inc. (NASDAQ:FGBI) Just Because It's Going Ex-Dividend

Simply Wall St.

a year ago

Don't Race Out To Buy First Guaranty Bancshares, Inc. (NASDAQ:FGBI) Just Because It's Going Ex-Dividend

Perfect Corp. Initiates Tender Offer: A Deep Dive Into What This Means For Investors

ACCESSWIRE

a year ago

Perfect Corp. Initiates Tender Offer: A Deep Dive Into What This Means For Investors

GlobeNewswire

a year ago

Shimmick Corporation Appoints Joe Del Guercio to Board of Directors

Shareholders in El Pollo Loco Holdings (NASDAQ:LOCO) are in the red if they invested three years ago

Simply Wall St.

a year ago

Shareholders in El Pollo Loco Holdings (NASDAQ:LOCO) are in the red if they invested three years ago

GlobeNewswire

a year ago

Shimmick Corporation Announces Third Quarter 2023 Earnings Release Date and Conference Call

Those who invested in Full House Resorts (NASDAQ:FLL) five years ago are up 145%

Simply Wall St.

a year ago

Those who invested in Full House Resorts (NASDAQ:FLL) five years ago are up 145%

Opthea to Present at the FLORetina 2023 Congress

GlobeNewswire

a year ago

Opthea to Present at the FLORetina 2023 Congress

Sky Harbour Group Announces the Second Closing of its Private Equity Placement with an Altai Capital Investment Vehicle for an Additional Aggregate Consideration of $15,000,000

Business Wire

a year ago

Sky Harbour Group Announces the Second Closing of its Private Equity Placement with an Altai Capital Investment Vehicle for an Additional Aggregate Consideration of $15,000,000

News Direct

a year ago

Renovaro Biosciences CEO unveils potential breakthrough therapies and AI partnerships for 2024

Civeo (CVEO)'s Technical Outlook is Bright After Key Golden Cross

Zacks

a year ago

Civeo (CVEO)'s Technical Outlook is Bright After Key Golden Cross

Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

Business Wire

a year ago

Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

BioLineRx Ltd. (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

BioLineRx Ltd. (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript

Renovaro BioSciences Eyes Opportunity in Precision Medicine Market

NewMediaWire

a year ago

Renovaro BioSciences Eyes Opportunity in Precision Medicine Market

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference

GlobeNewswire

a year ago

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference

Why Latham Group, Inc. (NASDAQ:SWIM) Could Be Worth Watching

Simply Wall St.

a year ago

Why Latham Group, Inc. (NASDAQ:SWIM) Could Be Worth Watching

Renovaro Biosciences CEO Provides Update on Combination with GEDiCube

NewMediaWire

a year ago

Renovaro Biosciences CEO Provides Update on Combination with GEDiCube

GlobeNewswire

a year ago

Shimmick Corporation Announces Pricing of Initial Public Offering

Lument Finance Trust Reports Third Quarter Results

PR Newswire

a year ago

Lument Finance Trust Reports Third Quarter Results

Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

a year ago

Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Hamilton Beach Brands Holding (NYSE:HBB) Has Affirmed Its Dividend Of $0.11

Simply Wall St.

a year ago

Hamilton Beach Brands Holding (NYSE:HBB) Has Affirmed Its Dividend Of $0.11

A Look At The Intrinsic Value Of Tredegar Corporation (NYSE:TG)

Simply Wall St.

a year ago

A Look At The Intrinsic Value Of Tredegar Corporation (NYSE:TG)

WESTERN COPPER AND GOLD PROVIDES GUIDANCE ON ENVIRONMENTAL AND SOCIO-ECONOMIC EFFECTS STATEMENT SUBMISSION AND INFRASTRUCTURE UPDATE

CNW Group

a year ago

WESTERN COPPER AND GOLD PROVIDES GUIDANCE ON ENVIRONMENTAL AND SOCIO-ECONOMIC EFFECTS STATEMENT SUBMISSION AND INFRASTRUCTURE UPDATE

Smith-Midland Corp (SMID) Reports Significant Revenue and Net Income Growth in Q3 2023

GuruFocus.com

a year ago

Smith-Midland Corp (SMID) Reports Significant Revenue and Net Income Growth in Q3 2023

Share on Social Networks: